Category: St. Jude Medical
A Danish study of patients with St. Jude Medical's recalled Riata defibrillator leads concludes that 1 in 10 lead wires poked through their protective coating after an average of 5.1 years.
Danish researchers reported this week that their latest studies of St. Jude Medical's (NYSE:STJ) recalled Riata defibrillator leads found that 1 in 10 had poked through their coating in an average of just over 5 years.
Medical device company St. Jude Medical launches a landmark study of its Enlightn renal denervation in order to find out whether the nerve ablating treatment has unexpected health benefits beyond lowering high blood pressure.
St. Jude Medical (NYSE:STJ) is aiming to take its renal denervation therapy a step further, looking for signs that the minimally invasive treatment improves health beyond lowering high blood pressure in patients with uncontrolled hypertension.
St. Jude Medical recalls its Amplatzer TorqVue FX delivery system over concerns about fractures in the core wire.
Corrected February 13, 2013, at 12:00 p.m. to clarify that the recalled component is part of the Amplatzer Atrial Septal Occluder.
The FDA issued the highest-risk label on St. Jude Medical's (NYSE:STJ) recall of its Amplatzer TorqVue FX delivery system.
St. Jude Medical touts new findings from its failed RESPECT trial, reporting that the Amplatzer PFO closure device demonstrated benefits over drug therapy alone.
Medical device giant St. Jude Medical (NYSE:STJ) resurrected data from its failed RESPECT study, touting additional analyses and benefits of its Amplatzer patent foramen ovale closure device.
MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.
MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.
St. Jude Medical expands a European transcatheter aortic valve implantation study to include a larger 25 mm valve in treatment of patients with severe aortic stenosis.
St. Jude Medical (NYSE:STJ) researchers implanted the 1st patient with a larger-sized Portico transcatheter aortic valve as part of the medical device maker's ongoing Portico TF EU trial.
Hedge fund goliath BlackRock Inc. boosts its stake in a bevy of medical device companies.
BlackRock Inc., 1 of the world's largest hedge funds, boosted its stake in a clutch of medical device companies, with 1 exception.